长非编码RNA 普拉德·威利/安吉尔曼区域RNA 6通过调节microRNA-106a-5p抑制质瘤的发展
Yongjun E1, Xianglin Zhang2, Heji Ma1
1Department of Radiology, The First Affiliated Hospital of Jinzhou Medical University, No. 2, Section 5, Renmin Street, Guta District, Jinzhou, 121000, Liaoning, China.
Biochemical genetics
|August 23, 2023
概括
长非编码RNA PWAR6 在质瘤中被下调,作为瘤抑制剂. 它通过调节microRNA-106a-5p来抑制质瘤细胞的生长和入侵,表明其作为预后生物标志物的潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 质瘤是常见的内瘤,具有侵入性生长和不良预后.
- 长非编码RNAs (lncRNAs) 是各种癌症中公认的生物标志物.
- PWAR6在质瘤发展中的作用及其机制尚不清楚.
研究的目的:
- 为了调查PWAR6在质瘤发育中的参与.
- 阐明质瘤中PWAR6的潜在分子机制.
- 评估PWAR6作为质瘤预后的潜在生物标志物.
主要方法:
- 聚合酶链反应 (PCR) 来评估质瘤中的PWAR6表达.
- 统计分析以评估临床意义.
- 细胞计数套件-8 (CCK-8) 和Transwell测定用于研究生物功能.
- 路西法雷斯记者试图调查潜在的机制.
主要成果:
- 在质瘤组织中,PWAR6的下调显著.
- 低调PWAR6与主要临床病理特征和患者预后不佳相关.
- PWAR6抑制了结质瘤细胞的生长,迁移和入侵.
- 过度表达的microRNA-106a-5p (miR-106a-5p) 减轻了PWAR6.6的抑制作用.
- 在PWAR6调节miR-106a-5p.
结论:
- 在质瘤中,PWAR6作为瘤抑制剂起作用.
- PWAR6作为质瘤的预后生物标志物起作用.
- PWAR6通过调节miR-106a-5p来发挥其作用.
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
piRNA - Piwi-interacting RNAs
6.9K
PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
6.9K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
RNA Interference
26.1K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.1K


